Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFANTS
NCT04417595Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Nov 2020
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of omega-3 fatty acid in Preterm labor (PTL), Tobacco Use Disorder (TUD), sponsored by Vanderbilt University Medical Center. Started Nov 2020; status: completed.
02
Drugs
omega-3 fatty acid
03
Conditions
Preterm labor (PTL)Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT04417595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04417595.